More Evidence Mindfulness Is Effective for Migraine More Evidence Mindfulness Is Effective for Migraine
Mindfulness-based stress reduction improves episode frequency, related disability, depression, and quality of life in patients with migraine, new research suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 26, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Moderna Reports COVID-19 Vaccine Safe and Efficacious for Kids
Moderna’s COVID-19 vaccine is safe and efficacious for children ages 6 to 11 years old who recieve two half doses, the company said today. That’s based on the results of its KidCOVE study, which involved more than 4,700 kids in that age group. The children participating in Moderna’s trial were randomly assigned to receive two half doses of the vaccine or two shots of a placebo. Those who got the vaccine generated adequate virus-fighting antibodies that met the U.S. Food and Drug Administration’s (FDA) requirements for efficacy, and the vaccine produced an immune response in nearly all the children. ...
Source: TIME: Health - October 25, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately t...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

The seven unusual reasons for your headache including bowel issues – how to help
HEADACHES are triggered by lifestyle or environmental factors but there are other surprising factors causing the pain. (Source: Daily Express - Health)
Source: Daily Express - Health - October 24, 2021 Category: Consumer Health News Source Type: news

The Evolving Understanding of Risk With CGRP mAbs The Evolving Understanding of Risk With CGRP mAbs
The authors explore potential adverse effects associated with CGRP monoclonal antibodies used for migraine prevention, highlighting some not currently noted in the package insert.Headache (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 22, 2021 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

U.S. CDC Advisory Committee Unanimously Recommends Johnson & Johnson COVID-19 Vaccine as a Booster for All Eligible Individuals Who Receive Authorized COVID-19 Vaccines
NEW BRUNSWICK, N.J., October 21, 2021 – Johnson & Johnson (the Company) today announced that the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP), has recommended its COVID-19 vaccine as a booster for all eligible individuals who receive an authorized COVID-19 vaccine. “Today’s recommendation supports the use of the Johnson & Johnson COVID-19 vaccine as a booster for eligible individuals in the U.S. regardless of which vaccine they initially receive,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientif...
Source: Johnson and Johnson - October 21, 2021 Category: Pharmaceuticals Source Type: news

Botox Cuts Frequency of Episodic Migraine, Need for Acute Meds Botox Cuts Frequency of Episodic Migraine, Need for Acute Meds
Botox injections cut the number of days per month on which patients experience high-frequency episodic migraines for up to a year, new research suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 21, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Relugolix Side Effects in Fibroids, Endometriosis May Be Minimal Relugolix Side Effects in Fibroids, Endometriosis May Be Minimal
Headache and hot flush occurred at similar rates with relugolix combination therapy or placebo, a study shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 21, 2021 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA
NEW BRUNSWICK, N.J., October 20, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for a booster dose of the Johnson & Johnson COVID-19 vaccine for adults aged 18 and older at least two months following primary vaccination with single-shot Johnson & Johnson COVID-19 vaccine; and for eligible individuals who received a different authorized or approved COVID-19 vaccine. The Johnson & Johnson booster shot will be the same formulation and dosage as the primary shot. The EUA follows a unanimous recomme...
Source: Johnson and Johnson - October 20, 2021 Category: Pharmaceuticals Tags: Latest News Source Type: news

Positive Results for DIY Nerve Stimulation in Episodic Migraine Positive Results for DIY Nerve Stimulation in Episodic Migraine
Self-administered external trigeminal nerve stimulation is superior to sham stimulation in relieving pain for patients with episodic migraine, results from a phase 3 study show.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 19, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

DIY Nerve Stimulation Effective in Episodic Migraine DIY Nerve Stimulation Effective in Episodic Migraine
Self-administered external trigeminal nerve stimulation is superior to sham stimulation in relieving pain for patients with episodic migraine, results from a phase 3 study show.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 19, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

New Antimigraine Drugs Linked With Less Risk for Adverse Events New Antimigraine Drugs Linked With Less Risk for Adverse Events
New classes of antimigraine drugs demonstrate efficacy and improved tolerability for patients with chronic migraine, according to new research.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 18, 2021 Category: Neurology Tags: Internal Medicine News Source Type: news

Erenumab Tied to Rapid Conversion From Chronic to Acute Migraine Erenumab Tied to Rapid Conversion From Chronic to Acute Migraine
The anti-calcitonin gene-related peptide (CGRP) monoclonal antibody erenumab is associated with rapid and sustained conversion from chronic to episodic migraine, new research suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 18, 2021 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Why Getting Tested for Covid-19 Can Include a Headache
Coronavirus testing prices vary widely and can reach into the hundreds of dollars, making it hard for some travelers to budget for the added expense. (Source: NYT Health)
Source: NYT Health - October 16, 2021 Category: Consumer Health News Authors: Concepci ón de León Tags: Tests (Medical) Coronavirus (2019-nCoV) Travel and Vacations Budget Travel Prices (Fares, Fees and Rates) Content Type: Service Source Type: news

Johnson & Johnson COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee
NEW BRUNSWICK, N.J., October 15, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted 19-0 to recommend Emergency Use Authorization (EUA) for a booster dose of the Johnson & Johnson COVID-19 vaccine for adults aged 18 and older at least two months following initial vaccination with the single-shot vaccine. The vote was based on findings from two Company clinical trials, including the Phase 3 ENSEMBLE 2 study, which evaluated a booster dose of the Johnson &...
Source: Johnson and Johnson - October 15, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Persistent Headache After Mild COVID-19 Persistent Headache After Mild COVID-19
Complaints of migraine-like post-COVID headache have become increasingly common in outpatient headache clinics, but as these three cases demonstrate, they may present very differently.Headache (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 15, 2021 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Janssen Showcases Commitment to Advancing Scientific Innovation in Pulmonary Arterial Hypertension (PAH) at CHEST 2021 Annual Meeting
TITUSVILLE, N.J. – October 14, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today 11* abstracts highlighting data from its pulmonary hypertension (PH) portfolio will be presented at CHEST 2021, the annual meeting of the American College of Chest Physicians, held virtually October 17-20.Data presentations from eight abstracts will provide additional evidence supporting the role of objective multiparameter risk assessment approaches in helping to optimize treatment and care for pulmonary arterial hypertension (PAH), as well as the impact of earlier and comprehensive therapy with ...
Source: Johnson and Johnson - October 14, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

He Was Shot by a Stranger but Treated Like a Criminal When He Reached the ER
When Greg Jackson Jr. thinks about the night he was shot, the most painful part of the memory isn’t that he almost died. It’s not the six surgeries he underwent, the half-year bedridden, or the image of his younger cousin using a shirt as a tourniquet to save his life. It’s not even the thought of the gunman. What brings on a flood of resentment is his reception at the hospital. After he was rolled off the ambulance on a stretcher, still clad in his bloody clothes, police officers—not doctors or nurses—greeted him and began peppering him with questions. Where was he when the shots rang out? W...
Source: TIME: Health - October 13, 2021 Category: Consumer Health News Authors: Melissa Chan Tags: Uncategorized COVID-19 Guns Health Care healthscienceclimate nationpod Source Type: news

Study: Triptans give best pain relief for migraines, but have more side effects than newer drugs
A class of drugs called triptans remains the most effective treatment for migraines, an analysis of data from more than 60 studies published Monday by JAMA Network Open found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 11, 2021 Category: Consumer Health News Source Type: news

Use of traumatic brain injury plasma biomarkers after a potentially concussive event - Dengler BA, April MD, Bayuk T, Brody D, Curley K, DeGraba TJ, Dennison DG, Ditzel R, Hooten KG, Meyer AC, Puffer RC, Pyne S, Stout K, Sindelar B, Sonka B, Shackelford SA.
Between 2000 and 2019 TBI affected over 417,503 service members worldwide, with 88% of those injuries being classified as mild (mTBI), also known as concussion.1 Common sequelae after mTBI include: headache, visual impairment, Post-Traumatic Stress Disorde... (Source: SafetyLit)
Source: SafetyLit - October 11, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Can migraines be untangled by new medical thinking?
Dr Peter Goadsby ’s pioneering work has changed our understanding of migraines. Eva Wiseman, who has endured them since she was a child, hears how he found his way to the source of the pain – and what can be done about itI started yawning, and that was it. That was the sign a migraine was beginning, that I was rolling slowly down that padded cliff. It was inevitable that this would happen half an hour before my interview with neurologist Dr Peter Goadsby, the man forcing the world to take migraines seriously, inevitable but not ideal, so I sipped my water and watched as he scrolled through his Zoom backgrounds....
Source: Guardian Unlimited Science - October 9, 2021 Category: Science Authors: Eva Wiseman Tags: Health Medical research Science Society Source Type: news

Migraines: What causes them? Expert explains why coronavirus could be to blame
MIGRAINES are a common health condition, affecting around one in every five women and around one in every 15 men. But what causes them? One expert claims post-pandemic stress disorder could be to blame. (Source: Daily Express - Health)
Source: Daily Express - Health - October 9, 2021 Category: Consumer Health News Source Type: news

Janssen Submits Application Seeking U.S. FDA Approval of STELARA ® (ustekinumab) for the Treatment of Pediatric Patients With Juvenile Psoriatic Arthritis
HORSHAM, PENNSYLVANIA, October 8, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking expanded approval of STELARA® (ustekinumab) to treat pediatric patients ages 5 years and older with juvenile psoriatic arthritis (jPsA).The filing is supported by extrapolation of data from nine studies across both adult trials in active PsA and adult and pediatric studies in moderate to severe plaque psoriasis, totaling 3,997 patients evaluated across these closely associa...
Source: Johnson and Johnson - October 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Role of Memantine in the Prophylactic Treatment of Migraine Role of Memantine in the Prophylactic Treatment of Migraine
Memantine has been used off-label for the prevention of episodic migraine. Does current evidence support its efficacy and safety for migraine prophylaxis?Headache (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 8, 2021 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Concussions and kids: Project co-led by UCLA gets $10 million grant from NIH
A research project co-led by theUCLA Steve Tisch BrainSPORT Programaimed at improving the assessment and treatment of concussions in school-aged children has been awarded $10 million by the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health.The grant to the Four Corners Youth Consortium, agroup of academic medical centers studying pediatric concussions, will supportConcussion Assessment, Research and Education for Kids, or CARE4Kids, a multisite study that will enroll more than 1,300 children and teens nationwide, including an estimated 240 in Southern California.CARE4Kids re...
Source: UCLA Newsroom: Health Sciences - October 7, 2021 Category: Universities & Medical Training Source Type: news

Migraine History May Raise Risk for Peripartum Depression, Anxiety
History of migraine linked to anxiety at gestational week 17, mixed depression and anxiety at gestational week 32 (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - October 7, 2021 Category: Psychiatry Tags: Family Medicine, Gynecology, Neurology, Psychiatry, Journal, Source Type: news

What Helps With My Migraines May Backfire for You
A neurologist and who gets migraines shares what helps her and what may -- or may not -- work for you. (Source: WebMD Health)
Source: WebMD Health - October 6, 2021 Category: Consumer Health News Source Type: news

Weird Migraine Triggers, Symptoms, and Types
Do you know what’s behind your migraine? Learn some of the lesser-known symptoms and triggers. (Source: WebMD Health)
Source: WebMD Health - October 6, 2021 Category: Consumer Health News Source Type: news

Migraine Doctor(s): Tips on What to Avoid
Some of the nation’s top migraine doctors offer tips and tricks to get your headaches under control. (Source: WebMD Health)
Source: WebMD Health - October 6, 2021 Category: Consumer Health News Source Type: news

What Helps With My Migraines May Backfire for You
A neurologist and who gets migraines shares what helps her and what may -- or may not -- work for you. (Source: WebMD Health)
Source: WebMD Health - October 6, 2021 Category: Consumer Health News Source Type: news

Johnson & Johnson Announces Submission of Emergency Use Authorization Amendment to the U.S. FDA to Support Booster of its Single-Shot COVID-19 Vaccine
NEW BRUNSWICK, N.J., October 05, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) announced it has submitted data to the U.S. Food and Drug Administration (FDA) to support use of a booster shot of the Johnson & Johnson COVID-19 vaccine in individuals 18 years of age and older.The submission includes recent results from the Phase 3 ENSEMBLE 2 study that found a booster of the Johnson & Johnson COVID-19 vaccine given 56 days after the primary dose provided 94 percent protection against symptomatic (moderate to severe/critical) COVID-19 in the U.S. (CI, 58%-100%) and 100 percent protection (CI, 33%-100%) a...
Source: Johnson and Johnson - October 5, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Migraine Therapies for Both Acute and Preventive Treatment Migraine Therapies for Both Acute and Preventive Treatment
Drs Stephanie J. Nahas and Anna Pace discuss migraine treatments that can work as acute and preventive options.American Headache Society and Medscape (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 4, 2021 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news

New Analysis Presented by Janssen at United European Gastroenterology Week (UEGW) Demonstrates Long-Term Safety Profile for STELARA ® (ustekinumab) in Older Patients Across Approved Indications
SPRING HOUSE, PENNSYLVANIA, October 4, 2021 – Today, the Janssen Pharmaceutical Companies of Johnson & Johnson announced a new analysis of STELARA® (ustekinumab) pooled safety data from 13 clinical studies across approved indications, showing rates of key safety events among adults 60 years and older treated with STELARA for up to five yearsa were similar to rates observed with placebo during the control phase of these trials.1,b Approved indications included adults with moderately to severely active Crohn’s disease (CD), moderately to severely active ulcerative colitis (UC), moderate to severe plaque p...
Source: Johnson and Johnson - October 4, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

What Causes Facial Pain?
Discussion Dental caries are one of the most common infections. It is usually caused by Streptococcus viridans. Dental caries are also quite preventable with brushing the teeth at least twice a day with a fluoridated dentifrice, use of dental floss, and preventative dental appointments with application of fluoride varnish and sealants as appropriate. Fluoridated water supplies also help. A review can be found here. Facial pain is often acute, self-limited and etiologies that may be obvious such as trauma or infection. Facial pain can also overlap with cranial pain (mainly headache), neck pain (often lymphadenopathy or musc...
Source: PediatricEducation.org - October 4, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Latest FDA-Approved Preventive Treatment For Migraine, Qulipta, Enters A Highly Competitive Market
On September 28th, the FDA approved a once-daily oral medicine, Qulipta (atogepant), for preventive treatment of episodic migraine in adults. It is the second FDA-approved, oral anti-CGRP drug for preventing migraine. The first was Nurtec ODT (rimegepant). (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 3, 2021 Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

Structural Aberrations of the Brain Associated With Migraine Structural Aberrations of the Brain Associated With Migraine
What have recent neuroimaging studies revealed about aberrant brain structure in patients with migraine?Headache (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - October 1, 2021 Category: Radiology Tags: Neurology & Neurosurgery Journal Article Source Type: news

Black patients ’ Lyme disease often diagnosed late, possibly due to missed signs
FINDINGSA UCLA study suggests that many physicians may not have the knowledge or training to properly recognize how Lyme disease appears on the skin of Black patients. The disease, caused by the tick-borne Borrelia bacterium, generally begins with a bull ’s-eye–shaped rash on the skin, along with fever, headache, chills and muscle pain; if not diagnosed promptly and treated with antibiotics, it can lead to more severe and long-lasting symptoms.UCLA ’s Dr. Dan Ly found that approximately 1 in 3 Black patients who were newly diagnosed with Lyme disease already had related neurological complications such as ...
Source: UCLA Newsroom: Health Sciences - October 1, 2021 Category: Universities & Medical Training Source Type: news

Flu and Covid jabs safe to be given at same time, study finds
Clinical trial on joint flu, Pfizer and AstraZeneca vaccinations reported only mild to moderate side-effectsCoronavirus – latest updatesSee all our coronavirus coverageFlu jabs are safe to give at the same time as the Pfizer or AstraZeneca Covid vaccines, according to the first clinical trial to investigate co-administering the shots in a single appointment.While some people experienced more side-effects with certain combinations of flu and Covid shots, the ailments were mainly mild to moderate, the study found. The most common side effects included pain at the injection site and temporary fatigue, headache or muscle...
Source: Guardian Unlimited Science - September 30, 2021 Category: Science Authors: Ian Sample Science editor Tags: Vaccines and immunisation Medical research Coronavirus UK news NHS Health Science Source Type: news

Migraine History Linked to Severe Hot Flashes Migraine History Linked to Severe Hot Flashes
Women with a history of migraine are more likely to experience severe hot flashes, according to research presented at the hybrid annual meeting of the North American Menopause Society.Medscape Medical News (Source: Medscape Med Students Headlines)
Source: Medscape Med Students Headlines - September 30, 2021 Category: Universities & Medical Training Tags: Ob/Gyn & Women ' s Health News Source Type: news

Persistent posttraumatic headaches and functioning in veterans: injury type can matter - Nabity PS, Jaramillo CA, Resick PA, McGeary CA, Eapen BC, Straud CL, Hale WJ, Houle TT, Litz BT, Mintz J, Penzien DB, Young-McCaughan S, Keane TM, Peterson AL, McGeary DD.
OBJECTIVE: To characterize the relationship between head trauma types (blast injury, blunt injury, combined blast+blunt injury) with subsequent headache presentations and functioning. BACKGROUND: Posttraumatic headaches (PTHs), the most common sequ... (Source: SafetyLit)
Source: SafetyLit - September 30, 2021 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

New Study Finds More Than A Third Of COVID-19 Patients Have Symptoms Months Later
The symptoms, such as headache, fatigue and cognitive dysfunction, persist or recur months after diagnosis, far more often than they do for the flu, researchers say.(Image credit: Kirsty Wigglesworth/AP) (Source: NPR Health and Science)
Source: NPR Health and Science - September 29, 2021 Category: Consumer Health News Authors: Scott Neuman Source Type: news

Botox for Migraine: How to Get Approved
You’ve heard Botox is a possible treatment for migraine. Will insurance foot the bill? (Source: WebMD Health)
Source: WebMD Health - September 29, 2021 Category: Consumer Health News Source Type: news

FDA Okays New Oral CGRP Antagonist for Migraine Prevention FDA Okays New Oral CGRP Antagonist for Migraine Prevention
The US Food and Drug Administration has approved atogepant, a novel calcitonin gene-related peptide receptor antagonist for the prevention of migraine.FDA Approvals (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - September 29, 2021 Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news

We must fight gender inequality in healthcare research | Letter
Less is known about women ’s health than men’s – that’s because research on the former is underfunded, saysSilvia HummelJessica Nordell raises several important issues facing women and people from ethnic minorities in accessing quality healthcare (The bias that blinds: why some people get dangerously different medical care, The long read, 21 September). Another important factor is that less is known about women ’s health than men’s.A recent analysis of the US National Institutes of Health expenditure (by far the largest funder of health research in the world) concluded that the &ldq...
Source: Guardian Unlimited Science - September 28, 2021 Category: Science Authors: Letters Tags: Women's health Society UK news Research funding US healthcare US news Gender Medical research Source Type: news

Why are so many suffering dreadful Covid symptoms but still testing NEGATIVE?
A dry cough, sniffles and a headache. Burning muscle pain. And everything you eat tastes like dust. It's a list of symptoms the British public have become all too familiar with - classic Covid. Or is it? (Source: the Mail online | Health)
Source: the Mail online | Health - September 25, 2021 Category: Consumer Health News Source Type: news

JOAN KRON: How Botox began as biological weapon and is now used to fight migraines and back pain
JOAN KRON: In 2019 there were 6.2 million Botox appointments carried out across the world, around 100,000 of them in the UK. And that's just for beauty. (Source: the Mail online | Health)
Source: the Mail online | Health - September 25, 2021 Category: Consumer Health News Source Type: news

The Best Tips We Have Learned About Migraine Self-Care During the Pandemic
With a stressful global pandemic meaning more time at home, people with migraine have unique needs when it comes to self-care. (Source: WebMD Health)
Source: WebMD Health - September 24, 2021 Category: Consumer Health News Source Type: news